IXC 0.00% 8.6¢ invex therapeutics ltd

Ann: Notice of Investor Call and Presentation, page-39

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 795 Posts.
    lightbulb Created with Sketch. 45
    https://hotcopper.com.au/data/attachments/3626/3626847-9037fc78aaf5e7f0631be9bec4e15e77.jpg

    https://hotcopper.com.au/data/attachments/3626/3626849-aeb7f41acf4c9ccf380d1c43afabb285.jpg

    https://hotcopper.com.au/data/attachments/3626/3626858-aabee39099151abfbf85c3b520e17bbf.jpg
    I would love to hear peoples thoughts on this. I would have assumed the a 1x per day formulation would be preferable as 1 per week < 7 per week therefore less money. However, I can definitely see the advantage of this deal, namely getting a CMO with a company that has been working with Exenatide for years will, especially if we don't have to pay anything upfront and won't have to pay royalties, just a predetermined agreement on margins.

    Just spitballing currently


 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.